HSA GMP Calibration Requirements for Singapore Pharmaceutical Manufacturers

The HSA GMP Framework and PIC/S Alignment

HSA GMP guidelines are aligned with PIC/S PE 009. The Pharmaceutical Inspection Co-operation Scheme Guide to Good Manufacturing Practice for Medicinal Products. PIC/S is the international benchmark for pharmaceutical GMP adopted by over 55 regulatory authorities worldwide, including HSA, TGA (Australia), Health Canada, and the regulatory bodies behind EU GMP. For Singapore pharmaceutical manufacturers, PIC/S compliance is not optional: it is the framework against which HSA inspectors assess manufacturing operations.

Singapore pharmaceutical manufacturers that export to ICH markets (the European Union, the United States, Australia, Japan), rely on PIC/S compliance as evidence of GMP equivalence. An HSA GMP Certificate issued following a satisfactory inspection is recognised by partner regulators as confirmation that the facility meets internationally accepted standards. Loss of GMP certification, or citation for serious GMP deficiencies, can result in import restrictions in those markets. A consequence that extends far beyond the local regulatory relationship.

Calibration requirements appear in multiple sections of PIC/S PE 009. Part I Chapter 3 (Premises and Equipment) requires that measuring equipment be calibrated and checked at defined intervals. Chapter 6 (Quality Control) reinforces the requirement in the context of laboratory instruments and analytical equipment. Where a facility uses computerised systems to manage calibration records, EU GMP Annex 11 also applies, requiring that electronic calibration management systems be validated and that audit trails be maintained. HSA GMP inspectors check calibration compliance across all three of these areas during site inspections.

Calibration findings are among the most commonly cited GMP deficiencies in HSA inspection reports. The most frequent issues include instruments with expired calibration due dates still in service, missing or illegible calibration labels, no documented procedure for managing out-of-tolerance instruments, and calibration certificates from providers who cannot demonstrate traceability to a national measurement standard. None of these findings requires a complex investigation. They are preventable with a well-structured calibration programme and appropriately accredited external calibration providers.

Which Instruments Are in GMP Scope

GMP calibration scope is defined by risk to product quality, patient safety, or data integrity. It is not defined by instrument type or cost. A simple thermometer used to monitor a stability chamber is in scope; an expensive analytical balance used only for non-critical weighing of packaging materials may be lower priority. The starting point is a documented instrument register that captures every piece of measuring equipment used in manufacturing, testing, and environmental monitoring, with a documented risk assessment assigning criticality to each instrument.

The following table sets out common instrument categories in pharmaceutical manufacturing, together with their typical criticality and calibration interval:

The criticality ratings above represent common industry practice. Each facility must document its own risk assessment justifying the criticality and interval assigned to each instrument class. A generic table cannot replace a site-specific analysis tied to the manufacturing process and product risk profile.

Calibration vs Qualification. The GMP Distinction

One of the most frequently misunderstood aspects of GMP instrumentation is the distinction between equipment qualification and periodic calibration. Both are mandatory. Neither replaces the other. Confusing them (or treating calibration as sufficient without qualification, or vice versa), is a common source of GMP findings.

Equipment Qualification (IQ/OQ/PQ)

Equipment qualification is performed at commissioning, after major repairs or relocations, and after significant software upgrades. It comprises three stages. Installation Qualification (IQ) confirms that the instrument has been installed in accordance with the manufacturer's specifications and the facility's design requirements. Correct utilities, environmental conditions, and documentation. Operational Qualification (OQ) verifies that the instrument operates within specified limits across its full operational range under defined test conditions. Performance Qualification (PQ) demonstrates that the instrument consistently performs as intended under actual process conditions. For complex equipment such as stability chambers, PQ typically includes a mapping study (a temperature and humidity uniformity survey across all positions in the chamber), to confirm that the chamber meets specifications throughout its usable volume.

Periodic Calibration

Periodic calibration is an ongoing operational verification: it checks whether the instrument's measurement accuracy has drifted from its last-known-good state. Calibration does not establish fitness for purpose (that is the role of qualification); it confirms that the instrument continues to measure accurately. For a temperature sensor in a stability chamber, calibration verifies that the sensor reading agrees with a reference standard within the specified tolerance. For an analytical balance, it verifies that the balance reads correctly across its operational weighing range.

A common GMP finding is manufacturers who perform regular calibration but lack adequate IQ/OQ documentation for critical equipment installed years earlier. The qualification gap is frequently discovered when a regulator asks for the original commissioning records and the site cannot produce them. The converse also occurs. Facilities with thorough qualification packages but expired calibration, treating the qualification as a permanent pass. Both situations are deficiencies. A valid qualification, however thorough, does not substitute for the ongoing evidence that the instrument is continuing to perform accurately.

Calibration Intervals. The Risk-Based Approach

HSA GMP does not prescribe a single fixed calibration interval for all instruments. The requirement is that intervals be defined, documented, and justified. This risk-based approach means that the interval for a stability chamber temperature sensor monitoring a critical long-term stability study will differ from the interval for a general-purpose thermometer used to check ambient laboratory temperature.

The factors that should inform the calibration interval decision include: the frequency of use (instruments in continuous service accumulate wear more quickly than those used occasionally); the criticality of the measurement to product quality or patient safety; the historical calibration data for the instrument class (instruments that have consistently been found within 20% of their tolerance at recall have a demonstrated performance history that may support a longer interval, while those found near or outside tolerance require shorter intervals); the manufacturer's recommended calibration interval; and the environmental conditions in which the instrument operates (temperature cycling, humidity, vibration, and chemical exposure all affect drift rates).

Common industry practice, accepted by HSA and PIC/S inspectors when supported by documented risk assessment, is 6 months for the most critical instruments (stability chambers, autoclaves, primary standards used to verify other instruments); 12 months for most precision analytical instruments; and up to 24 months for non-critical instruments with a well-documented performance history showing stable readings over multiple calibration cycles.

Calibration intervals must be recorded in the instrument's calibration plan, master calibration schedule, or SOP, with the documented rationale. Where an instrument is recalled early due to suspected drift or following an incident, this early recall must itself be documented. Instruments must carry a calibration label clearly showing the calibration date and next due date. Or be tracked in a calibration management system that provides equivalent visibility to operators on the floor. An instrument found in use without a current calibration label, or beyond its due date, is an immediate GMP finding.

Out-of-Tolerance Procedures. A Critical GMP Requirement

Finding an instrument out of tolerance is not in itself a GMP failure. Instruments drift, particularly in demanding manufacturing environments, and a well-managed calibration programme will occasionally find instruments outside their acceptance criteria. What constitutes a GMP failure is the absence of a documented procedure to respond. Or the failure to follow the procedure when an out-of-tolerance condition is found.

PIC/S PE 009 requires written procedures for out-of-tolerance (OOT) instruments. The procedure must be followed consistently, and the entire response documented as a quality record. The required steps are:

1. Immediately quarantine the instrument and affix a clearly visible out-of-service label to prevent further use
2. Identify all products manufactured, tested, or environmental conditions monitored with the instrument since its last confirmed in-tolerance calibration. This defines the potential impact period
3. Conduct an impact assessment: could the out-of-tolerance condition have affected product quality, patient safety, or data integrity? The assessment must consider the magnitude of the drift, the parameter being measured, whether the parameter is a Critical Control Point or a release specification, and whether the affected product is still under quarantine or has already been distributed
4. Raise a deviation or non-conformance report that captures the finding, the impact assessment, and the proposed response
5. Implement Corrective and Preventive Action (CAPA) to address the root cause, whether that is instrument wear, environmental damage, inadequate storage, or an interval that proved too long
6. Re-verify the instrument (confirm it is now in tolerance after repair or adjustment) before returning it to service

The impact assessment is invariably the most challenging step in the OOT procedure. It requires the quality team to trace every use of the instrument back to the last known-good calibration date, identify every product batch and every test result potentially affected, and make a documented, defensible judgement about whether the out-of-tolerance condition could have resulted in a product quality or patient safety impact. Where the instrument measured a parameter that is not a Critical Control Point, and where the magnitude of the drift is small relative to the specification limit, the impact assessment may be straightforward. Where the instrument was used to release product directly or to monitor a sterilisation cycle, the assessment requires much more rigour. Potentially including batch recall or re-testing.

HSA inspectors specifically look for the OOT procedure in documented form, evidence that it has been followed for any OOT events in the inspection period, documented impact assessments that are substantive (not formulaic), evidence of batch review and traceability of affected products, and closure of the deviation with CAPA that is proportionate to the risk. A site that can demonstrate a consistent, well-documented OOT response (even if OOT events have occurred), is in a fundamentally stronger position than one that has simply had no OOT events but cannot show a procedure that would be followed if one arose.

Calibration Records. What Must Be Retained

A GMP-compliant calibration record is not merely a certificate of calibration. It is a complete quality document that must demonstrate every element of the calibration to a regulatory inspector who may never have visited the facility and who is relying entirely on the written record to reconstruct what occurred. The minimum content required by PIC/S PE 009 and accepted by HSA inspectors includes:

• Unique instrument identification. Model number, serial number, and the facility's internal asset or tag number
• Calibration date and next calibration due date
• Reference to the calibration method or procedure used
• Nominal or reference values applied during calibration, and the measured values at each point. The as-found and as-left data
• The applicable tolerance limits and a clear pass or fail determination at each measurement point
• Measurement uncertainty of the calibration, expressed in accordance with GUM (the Guide to the Expression of Uncertainty in Measurement)
• Environmental conditions (temperature, relative humidity) during calibration
• Identity of the calibration technician who performed the calibration
• Reference to the calibration standards used, including their own calibration certificate numbers and the next due date of those standards. This establishes the traceability chain

SAC-SINGLAS accredited calibration certificates issued by Unitest contain all of these elements as a matter of course. The accreditation scope independently verifies that the reference standards used are themselves calibrated and NMC-traceable, that the measurement uncertainty is calculated in accordance with GUM, and that the laboratory's personnel are competent. This removes the need for the pharmaceutical manufacturer to independently verify any element of the traceability chain. The SAC-SINGLAS accreditation provides that assurance.

Record retention under HSA GMP is more demanding than many manufacturers realise. The requirement is to retain calibration records for at least 1 year beyond the shelf life of the last product manufactured or tested with the instrument. Subject to a minimum retention period of 5 years. For products with a 2-year shelf life, this means a minimum of 3 years from the calibration date. For products with a 5-year shelf life (common for many injectable biologics and some small-molecule medicines), this extends to 6 years from the calibration date, and potentially longer if the product was still on the shelf at the time. Manufacturers exporting to the United States must also consider the FDA's requirements, which may be longer for certain product classes. Records must be legible, retrievable within a reasonable timeframe, and protected against deterioration and loss. Electronic records must comply with data integrity principles (ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available)), and if exporting to the US, must meet 21 CFR Part 11 requirements for electronic records; if exporting to the EU, EU GMP Annex 11.

SAC-SINGLAS and NMC Traceability

Traceability is the word that appears most frequently in GMP calibration requirements, and it is also the word most incompletely understood by manufacturers seeking to comply. In the GMP context, measurement traceability means the existence of an unbroken documented chain of calibrations connecting the instrument being used in manufacturing to the national measurement standard for the relevant quantity (in Singapore, the standards maintained by the National Metrology Centre (NMC) at A*STAR), and from NMC to the fundamental SI units of measurement.

SAC-SINGLAS (the Singapore Accreditation Council's Singapore Laboratory Accreditation Scheme), provides formal, independent, third-party verification that a calibration laboratory meets the requirements of ISO/IEC 17025:2017 for a defined scope of calibration activities. An SAC-SINGLAS certificate issued under the laboratory's accredited scope is not merely a declaration by the laboratory that its standards are traceable. It is a statement backed by a periodic assessment by SAC's technically qualified assessors that the laboratory's reference standards are calibrated against NMC-traceable standards, that the calibration procedures are documented and followed, that the measurement uncertainty is correctly calculated, and that the personnel are competent. This independently verified traceability is what PIC/S PE 009 and HSA GMP require.

Unitest holds SAC-SINGLAS accreditation under scope LA-2023-0845-C. Every calibration certificate issued within the accredited scope references this accreditation number, identifying it as an accredited certificate. PIC/S inspectors from any of the 55+ PIC/S member authorities (including the EU, TGA, and Health Canada), recognise SAC-SINGLAS certificates as satisfying the traceability requirement without further verification.

Non-accredited calibration providers present a materially different situation. A non-accredited provider may claim traceability on their certificates, but that claim is self-asserted rather than independently verified. A PIC/S inspector who asks for the traceability evidence and receives only a non-accredited provider's certificate will require the manufacturer to demonstrate the full traceability chain themselves. Producing the calibration certificates for the provider's reference standards, the calibration certificates for the standards used to calibrate those standards, and so on, up to NMC. In practice, many manufacturers who have used non-accredited providers cannot produce this chain, because they never thought to request it. The result is a GMP finding that is entirely avoidable by specifying SAC-SINGLAS accredited calibration from the outset.